article thumbnail

Outsourcing In Drug Development: A Key Strategy for Sustainable Growth

Electronic Health Reporter

This article is copyrighted strictly for Electronic Health Reporter. One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development. Illegal copying is prohibited. The pharmaceutical industry is constantly evolving, driven by advances in science, technology, and patient needs.

article thumbnail

Pharma – 2025 Health IT Predictions

Healthcare IT Today

This transformation will particularly benefit organizations that can effectively combine AI expertise with traditional pharmaceutical knowledge, creating new competitive advantages in drug development efficiency, cost management, and market responsiveness. We could not do this without all of your support. Let us know on social media.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare AI Bias: Reasons and Resolutions

Healthcare IT Today

The following is a guest article by Anand Shroff, President at Verantos.

article thumbnail

Weekly Roundup – January 4, 2025

Healthcare IT Today

Each week, well be providing a look back at the articles we posted and why theyre important to the healthcare IT community. On the pharma front, expect an emphasis on AI for inventory management and targeted drug development , plus a shake-up in the market for weight-loss drugs.

EHR 90
article thumbnail

How Technology Is Improving Success Rates In Drug Clinical Trials

Electronic Health Reporter

This article is copyrighted strictly for Electronic Health Reporter. Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. Illegal copying is prohibited.

article thumbnail

The Impact of Agile In The Pharmaceutical Industry

Electronic Health Reporter

This article is copyrighted strictly for Electronic Health Reporter. As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. Without a direct relationship with […].

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.

BioTech 112